No abstract available
MeSH terms
-
Antineoplastic Agents, Alkylating / adverse effects
-
Antineoplastic Combined Chemotherapy Protocols / adverse effects
-
Chromosomes, Human, Pair 11 / genetics
-
DNA-Binding Proteins / genetics
-
Enzyme Inhibitors / adverse effects
-
Gene Deletion
-
Hematopoietic Stem Cell Transplantation / adverse effects
-
Histone-Lysine N-Methyltransferase
-
Humans
-
Leukemia* / etiology
-
Leukemia* / therapy
-
Myeloid-Lymphoid Leukemia Protein
-
Neoplasms, Second Primary* / etiology
-
Neoplasms, Second Primary* / therapy
-
Proto-Oncogenes*
-
Topoisomerase II Inhibitors
-
Transcription Factors*
-
Translocation, Genetic / drug effects
Substances
-
Antineoplastic Agents, Alkylating
-
DNA-Binding Proteins
-
Enzyme Inhibitors
-
KMT2A protein, human
-
Topoisomerase II Inhibitors
-
Transcription Factors
-
Myeloid-Lymphoid Leukemia Protein
-
Histone-Lysine N-Methyltransferase